Daniel T. Scavilla - Apr 21, 2022 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
President, CEO, Director
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Stock symbol
GMED
Transactions as of
Apr 21, 2022
Transactions value $
$0
Form type
4
Date filed
4/22/2022, 04:30 PM
Previous filing
Jan 31, 2022
Next filing
Feb 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Award $0 +60K $0.00 60K Apr 21, 2022 Class A Common Stock 60K $79.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on April 21, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on April 21, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.